Renflexis and Migraine - a phase IV clinical study of FDA data

Summary:

Migraine is found among people who take Renflexis, especially for people who are female, 30-39 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Renflexis and have Migraine. It is created by eHealthMe based on reports of 667 people who have side effects when taking Renflexis from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 24, 2023

667 people reported to have side effects when taking Renflexis.
Among them, 11 people (1.65%) have Migraine.

What is Renflexis?

Renflexis has active ingredients of infliximab-abda. eHealthMe is studying from 670 Renflexis users for its effectiveness, alternative drugs and more.

What is Migraine?

Migraine (headache) is found to be associated with 2,958 drugs and 2,263 conditions by eHealthMe.

Number of Renflexis and Migraine reports submitted per year:

Time on Renflexis when people have Migraine *:

Gender of people who have Migraine when taking Renflexis *:

female: 100 %
male: 0.0 %

Age of people who have Migraine when taking Renflexis *:

Common drugs people take besides Renflexis *:

Common side effects people have besides Migraine *:

Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 7 people, 63.64%
High Blood Pressure: 6 people, 54.55%
Dizziness: 5 people, 45.45%
Arrhythmias (irregular heartbeat): 5 people, 45.45%
Joint Pain: 4 people, 36.36%
Dehydration (dryness resulting from the removal of water): 3 people, 27.27%
Depressed Level Of Consciousness: 3 people, 27.27%
Drowsiness: 3 people, 27.27%
Gastric Ulcer (stomach ulcer): 3 people, 27.27%
Vulvovaginal Mycotic Infection (vulvovaginal fungal infection): 3 people, 27.27%

Common conditions people have *:

Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 8 people, 72.73%
Headache (pain in head): 3 people, 27.27%
Gastric Ulcer (stomach ulcer): 3 people, 27.27%
Anaemia (lack of blood): 3 people, 27.27%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Endometrial Cancer: 1 person, 9.09%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Renflexis and have Migraine?

Check whether Migraine is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Migraine and when was it recovered:

Migraine in Renflexis

Expand to all the drugs that have ingredients of infliximab-abda:

Migraine and drugs with ingredients of infliximab-abda

Alternative drugs to, pros and cons of Renflexis:

Renflexis (670 reports)

Migraine treatments and more:

Migraine (194,005 reports)

COVID vaccines that are related to Migraine:

Common drugs associated with Migraine:

All the drugs that are associated with Migraine:

Migraine (2,959 drugs)

Common conditions associated with Migraine:

All the conditions that are associated with Migraine:

Migraine (2,263 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab-abda (the active ingredients of Renflexis) and Renflexis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.